Latest Breaking News On - New jersey net operating losses - Page 1 : comparemela.com

CorMedix Inc (CRMD) Q1 2024 Earnings: Net Loss Widens, Misses Analyst Forecasts

CorMedix Inc (CRMD) Q1 2024 Earnings: Net Loss Widens, Misses Analyst Forecasts
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Joe todiscoCormedix incNew jersey net operating losses

Palatin Technologies, Inc : Palatin Reports Fourth Quarter and Fiscal Year Ended 2023 Financial Results and Provides Corporate Update

Palatin Technologies, Inc : Palatin Reports Fourth Quarter and Fiscal Year Ended 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesCh ungch ong buktoSouth koreaNew jerseyHainan provinceBaden wübergFosun pharmaCarl spanaSecurities exchangeKwangdong pharmaceuticalsPalatin technologies incPrnewswire palatin technologies incExchange commissionDry eye diseaseData expected lateCalendar year

Palatin Reports Fourth Quarter and Fiscal Year Ended 2023 Financial Results and Provides Corporate Update

Enrollment in Phase 3 PL9643 MELODY-1 Study in Dry Eye Disease (DED) is Complete with 570 Patients Enrolled Topline Data Expected Late 4Q Calendar Year 2023.

United statesCh ungch ong buktoSouth koreaNew jerseyHainan provinceCarl spanaFosun pharmaPalatin technologies incKwangdong pharmaceuticalsSecurities exchangePrnewswire palatin technologies incDry eye diseaseData expected lateCalendar yearClinical efficacy across multiple signsDry eye

SCYNEXIS : 10-K Filing | MarketScreener

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K . | March 31, 2023

State of new jerseyNew jerseyUnited statesHong kongUnited kingdomNew south walesSouth africaRussian federationDavid hastingsBrian philippe tinmouthMarco tagliettiAzoles noxafilStevenc gilmanChristine coyneHistoplasmaandblastomycesgenera candidaandaspergillusgeneraArmando anido

Agile Therapeutics Reports First Quarter 2022 Financial

Twirla Experienced Another Quarter of Double-Digit Demand Growth in First Quarter 2022 Twirla Business Plan Progressing Company Anticipates Future 2022.

United statesNew jerseyAfaxys pharmaMatt rileyAl altomariHead of investor relations corporate communicationsExchange commissionAgile therapeutics incCompany anticipatesSecurities exchangeSymphony health solutionsDouble digit demand growthFirst quarterAnticipates futureOperating expensesHost conference call today